Tumeurs cérébrales : neurotoxicité des traitements et évaluations cognitives (notice n° 1028669)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03416cam a2200361 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250125171857.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Durand, Thomas |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Tumeurs cérébrales : neurotoxicité des traitements et évaluations cognitives |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2016.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 23 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | RésuméL’amélioration des traitements neuro-oncologiques ces dernières années permettant une survie plus longue des patients atteints de tumeurs cérébrales fait émerger la problématique des effets secondaires à long terme. Parmi ces effets secondaires, les troubles cognitifs sont au premier plan et impactent lourdement la qualité de vie des patients. Leur prise en compte constitue actuellement un challenge majeur en neuro-oncologie et nécessite un effort en recherche clinique ainsi que dans le suivi à moyen et à long terme des patients en pratique courante. Les troubles cognitifs peuvent être causés par la progression tumorale et/ou par la récidive tumorale, mais sont souvent provoqués par la neurotoxicité inhérente aux traitements. L’objectif de cet article est de présenter les troubles cognitifs induits par les traitements anti-tumoraux ainsi que par les traitements concomitants les plus courants en neuro-oncologie. Nous exposons ensuite les principaux biais auxquels se heurte l’évaluation neuropsychologique dans ce contexte et présentons la batterie cognitive proposée par le Grec-Onco, actuellement utilisée dans différents protocoles de recherche clinique. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Brain tumours: treatments-related neurotoxicity and cognitive assessmentsImprovements of neuro-oncologic treatments during the last decades resulted in longer survival of patients and thus associated side effects became more visible. Among these side effects, cognitive impairments are ones of the most important and are closely linked to health-related quality-of-life decrements. Consequently, its consideration became of high importance in clinical trials as well as in individual follow-up. Indeed, cognitive defects represent an early marker of tumour progression and/or recurrence at the early stages of the brain tumour but can also be related to treatments’ neurotoxicity that clinicians have to consider in long survivors. The objective of this communication is to briefly present anti-tumour and concomitant treatment-related cognitive impairments. Then, we expose major bias encountered in neuropsychology in this context and present the Grec-Onco cognitive battery, which is currently used in different clinical trials. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | tumeurs cérébrales |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | neurotoxicités |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | troubles cognitifs |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | brain neoplasm |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | adverse effects |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cognition disorders |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Léger, Isabelle |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bompaire, Flavie |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Boone, Mathieu |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moroni, Christine |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Delgadillo, Daniel |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dornier, Stéphanie |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Psimaras, Dimitri |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Noël, Georges |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Taillia, Hervé |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ricard, Damien |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Revue de neuropsychologie | Volume 8 | 3 | 2016-10-03 | p. 192-200 | 2101-6739 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-de-neuropsychologie-2016-3-page-192?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-de-neuropsychologie-2016-3-page-192?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux